Hypopigmentation of a papillary carcinoma arising in a black thyroid

Modern Pathology

Volumn 12, Issue 12, 1999, Pages 1181-1185

  Thompson, A D ^a,b   Pasieka, J L ^a   Kneafsey, P ^a   DiFrancesco, L M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Black thyroid; Minocycline; Papillary carcinoma

Indexed keywords

MINOCYCLINE;

ADULT; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPIGMENTATION; PIGMENT DISORDER; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADULT; ANTI-BACTERIAL AGENTS; BIOPSY, NEEDLE; CARCINOMA, PAPILLARY; FEMALE; HUMANS; HYPOPIGMENTATION; MINOCYCLINE; PIGMENTATION DISORDERS; THYROID DISEASES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0033378675     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Benitz KF, Roberts GKS, Yusa A. Morphological effects of minocycline in laboratory animals. Toxicol Appl Pharmacol 1967;11:150-70.
2. Atwood HD, Dennett X. A black thyroid and minocycline treatment. BMJ 1976;6:1109-10.
3. Saul SH, Dekker A, Lee RE, Breitfeld V. The black thyroid. Arch Pathol Lab Med 1983;107:173-7.
4. Billano RA, Ward WQ, Little WP. Minocycline and black thyroid. JAMA 1983;249:1887.
5. Reid JD. The black thyroid associated with minocycline therapy. A local manifestation of a drug-induced lysosome/substrate disorder. Am J Clin Pathol 1983;79:738-46.
6. White SW, Besanceney C. Systemic pigmentation from tetracycline and minocycline therapy. Arch Dermatol 1983; 119:1-2.
7. Alexander CB, Herrera GA, Jaffe K, Yu H. Black thyroid: Clinical manifestations, ultrastructural findings and possible mechanisms. Hum Pathol 1985;16:72-8.
8. Delprado WJ, Carter JJ. Minocycline hydrochloride and thyroid pigmentation. A case report and histological and ultrastructural study. Pathology 1984;16:339-41.
9. Ohaki Y, Misugi K, Hasegaura H. "Black thyroid" associated with minocycline therapy: a report of an autopsy case and review of the literature. Acta Pathol Jpn 1986;36: 1367-75.
10. Medeiros LJ, Federman M, Silverman ML, Balogh K. Black thyroid associated with minocycline therapy. Arch Pathol Lab Med 1984;108:268-9.
11. Landas SK, Schelper RL, Tio FO, Turner JW, Moore KC, Bennett-Gray J. Black thyroid syndrome: exaggeration of a normal process? Am J Clin Pathol 1986;85:411-8.
12. Landas SK, Marsh WL, Schuller DE, Rao MK, Wajda KJ. Nonpigmented papillary carcinoma in a black thyroid gland. Arch Otolaryngol Head Neck Surg 1990;116:735-7.
13. Onyia JN, Forrest LA, Forsthoefel K. Papillary carcinoma associated with black thyroid gland. Am J Otolaryngol 1996; 17:299-302.
14. Wajda KJ, Wilson MS, Lucas J, Marsh WL. Fine needle aspiration cytologic findings in the black thyroid syndrome. Acta Cytol 1988;32:862-5.
15. Noble JG, Christmas TJ, Chapple C, Katz D, Milroy EJG. The black thyroid: an unusual finding during neck exploration. Postgrad Med J 1989;65:34-5.
16. Barsoum GH, Ryley NG, Barros D'Sa AA. Minocycline and black thyroid. J R Coll Surg Edinb 1990;35:387-8.
17. Faddis DM, Daraca PJ, Krementz ET. Oxyphilic (Hurtle cell) adenoma arising in a black thyroid. South Med J 1990;83: 476-8.
18. Keyhani-Rofagha S, Kooner DS, Landas SK, Keyhani M. Black thyroid: a pitfall for aspiration cytology. Diagn Cytopathol 1991;7:640-2.
19. Purdue B. An incidental autopsy finding of black thyroid associated with minocycline therapy. Med Sci Law 1992;32: 148-50.
20. Folsom DL, Gauderes MWL, Dahms WT. Nodular hyperplasia, black thyroid, and chronic minocycline ingestion in a teenager. Arch Surg 1992;127:1476-7.
21. Pastolero GC, Asa SL. Drug related pigmentation of the thyroid associated with papillary carcinoma. Arch Pathol Lab Med 1994;118:79-83.
22. Kelly RG, Kanegis LA. Metabolism and tissue distribution of radioisotopically labeled minocycline. Toxicol Appl Pharmacol 1967;11:171-83.
23. Gordon G, Sparano M, Kramer AW, Kelly RG, Iatropoulos MJ. Thyroid gland pigmentation and minocycline therapy. Am J Pathol 1984;117:98-109.
24. Tajima K, Miyagawa J-I, Nakajima H, Shimizu M, Katayama S, Mashita K, et al. Morphologic and biochemical studies on minocycline-induced black thyroid in rats. Toxicol Appl Pharmacol 1985;81:393-400.
25. Enochs WS, Nilges MJ, Swartz HM. The minocycline-induced thyroid pigment and several synthetic models: Identification and characterization by electron paramagnetic resonance spectroscopy. J Pharmacol Exp Ther 1993; 266:1164-76.
26. Kurosumi M, Fujita H. Fine structural aspects of the black thyroid induced by minocycline, and the effects of a low iodine diet, propylthiouracil, thyroxine tablet and TSH, on the black discoloration of the rat thyroid. Virchows Arch B Cell Pathol Incl Mol Pathol 1985;48:219-27.
27. Kurosumi M, Fujita H. Fine structural aspects on the fate of rat black thyroids induced by minocycline. Virchows Arch B Cell Pathol Incl Mol Pathol 1986;51:207-13.
28. Taurog A, Dorris ML, Doerge DR. Minocycline and the thyroid: antithyroid effects of the drug and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland. Thyroid 1996;6:211-9.
29. Doerge DR, Divi RL, Deck J, Taurog A. Mechanism for the anti-thyroid action of minocycline. Chem Res Toxicol 1997; 10:49-58.